the dose of hydrallazine was increased to a maximum of 400 mg daily. Using this scheme of treatment it was possible to keep the diastolic pressure below 100 mmHg in all but 8 patients who received, in addition, mecamylamine 2-5 mg twice daily, rising to a maximum of 10 mg twice daily. In order to assess the effect of the hypotensive therapy on foetal survival, the foetal mortality in the 145 patients treated with hypotensive therapy from 1955 to 1959 was compared with that of the previous series, 1947 to 1954. The foetal mortality was 28 (17 %.) in the untreated group and 27 (18%) in the treated group: these results are not matched for other factors and therefore are not strictly comparable; however, when the pregnancies in the two groups are matched for age, parity and initial diastolic pressure, there is no significant difference in the treated and untreated pregnancies (X2 on total= 0 0345; d.f.=l; 090>P>0 80). The matching was by five-year age groups and individual parities up to para-4.
That these results might have been influenced by other major factors affecting the fcetal mortality is unlikely as there was no significant difference in the two groups for the induction rate (x2=0 022; d.f. = 1; 0 90 >P >0 80), maturity at delivery (x'=0 046; d.f.=l; 090>P>0 80), duration in hospital (x2=2-30; d.f.=6; 0 90> P>0 80), and fretal mortality in a previous pregnancy (x2= 1 59; d.f.= 1; 030>P>0-20).
In the third series, 1960-5, further comparisons of patients treated with and without hypotensive agents are made. Although the majority of patients in this series also received reserpine and hydrallazine, several of the patients were treated with protoveratrine or some of the newer preparations such as methyldopa. Of the 250 patients in this third series, 69 were treated with hypotensive therapy and 181 had no hypotensive therapy.
The fcetal mortality was 13 (19%) in the treated group and 11 (6%) in the untreated group. The increase in feetal mortality in the treated group is due to the fact that there was some selection of the more severe cases for hypotensive therapy, in fact, 32 (approximately 50 %) of the patients who had hypotensive therapy had initial diastolic pressures of 100 mmHg or over compared with only 41 (23%) of those who had no hypotensive therapy. It was possible, however, to match 58 patients treated with and without hypotensive therapy for age, parity, initial diastolic blood pressure, proteinuria, maturity and method of delivery. The matching was exact in all patients and not according to various groups. The feetal mortality was 4 in the patients who received no hypotensive therapy and 7 in the patients treated with hypotensive therapy. This difference in the foetal mortality was not significant (x2=088; d.f.= 1; 0 50>P>0 30). Although the figures are small these results also suggest that in patients whose initial diastolic blood pressure is less than 100 mmHg the fetal prognosis may be adversely affected by hypotensive therapy. 
Chronic Hypertension and Perinatal Mortality
That the traditional teaching on the subject of chronic hypertension and perinatal mortality needs close re-examination is shown by a study of all cases of chronic essential hypertension treated and delivered in the Simpson Memorial Maternity Pavilion during the decade from 1955 to 1964. The number of mothers was 1,226, of whom 44 aborted, leaving a total of 1,182 mothers delivered after the 28th week. There were 19 sets of twins, making a total of 1,201 babies of whom 51 succumbed. Hypertension was diagnosed in any woman who had had a blood pressure recorded as over 140 systolic and over 90 diastolic on two occasions after her admission to hospital. Cases of pre-eclampsia were excluded and the remaining chronic hypertensives were then graded as mild, moderate or severe. Patients with a blood pressure over but hovering round the 140/90 level were classified as 'mild'; those over but hovering round the 160/90 level as 'moderate' and those with a systolic blood pressure of more than 180 on several occasions as 'severe'. Stillbirths included every fetus which survived in utero for a period of 28 weeks but did not survive delivtry. Neonatal deaths included all those babies who died before the 28th day after delivery.
Nine abortions were therapeutic, so the spontaneous abortion rate in the series-(35 in 1,217) was under 3 % -a very low figure. It has Section ofObstetrics and Gynwcology Since pre-eclampsia is more dangerous for the foutus than simple chronic hypertension, one ce to terminate the pregnancy must therefore ask whether the woman who rtensive woman at sight and starts a pregnancy in a hypertensive state is more rapeutic abortions were done likely than her normotensive sister to end by ;ions. This conservative policy becoming pre-eclamptic.
vr there was only one maternal This is treacherous ground because precise At the age of 23 this mildly classification is so difficult. But our figures, for It was having her first baby: what they are worth, suggest that the ultimate brain hemorrhage at the site emergence of pre-eclampsia in the hypertensive Ls aneurysm in the ponsa woman (with an incidence of 139 out of 1,220 d have foreseen.
patients, or 11'5%) is rather more likely than in )ression of the hypertensive the woman who starts her pregnancy in a le when compared with the normotensive state (2,847 out of 33,742 patients, )le of Scotland and with the or 8-6 %). Figures relating to the emergence of a own hospital during the same state of severe pre-eclampsia are definitely more 'he hypertensive series shows convincing: the risk here seems to be of the order rinatal mortality as that for of 3-5 % (or 42 out of 1,220 patients) as compared md, and the figure is rather with just over 0-5 % (or 202 out of 33,742 patients) our total hospital series. At in booked normotensive women. That is to say idition of hypertension seems it is nearly seven times as high. isk for the foetus: but there is When pre-eclampsia supervenes on an existing )n of stillbirths and a lesser chronic hypertensive state the perinatal mortality ital deaths in the hypertensive is high, amounting to 151 per 1,000 in the whole group of 167 births (Table 2) . On the other hand wever, the picture assumes a the total perinatal mortality rate is almost Wildly hypertensive mothers identical in all cases of severe pre-eclampsia ter results than the average, whether the mother was hypertensive or normovothers who are moderately tensive at the beginning of the pregnancy (297 cne too badly. It is in the and 271 per 1,000 respectively). It is noteworthy lat the traditional views seem that in both these groups the stillbirth/neonatal in this group, however, with a death ratio is essentially of the pre-eclamptic pattern (with a high proportion of neonatal deaths) suggesting that it is pre-eclampsia rather than the hypertensive state which is the really lethal factor. In brief, if the chronic hypertensive patient does develop severe pre-eclampsia, she is no more likely to lose her child than is her normotensive sister suffering from the same later complicationbut there does seem to be an increased risk of her becoming severely pre-eclamptic.
The risk of accidental antepartum hemorrhage must also be assessed: surprisingly, our figures show that the average hypertensive woman is actually less likely than her normotensive sister to suffer an accidental antepartum h2emorrhage lethal to the feetus, the relative incidence of such heemorrhage being just over 0-6% for 33,150 booked normotensive women and just over 0 45 % for 1,081 suffering from chronic essential hypertension.
On the other hand again, when graded, the risk is seen to be very definitely present in the case of women suffering from severe chronic hypertension (6-5 % for 45 mothers) -while it is subnormal in both the mild and moderate grades.
With regard to those cases in which the outcome was not successful, there are two basic questions: When did these babies die? And why did they die? The babies of 4 diabetic mothers have been excluded from this analysis which is therefore based on a total of 47 foetal fatalities.
Comparing the fatality stage of all stillbirths and neonatal deaths occurring in our hospital practice as a whole with those occurring in all women suffering from all degrees of chronic hypertension, it is evident that deaths occurring before the onset of labour appear to be rather commoner in the hypertensive than in the normotensive group (Table 3) . Deaths during labour appear to be slightly rarer in the hypertensive groupprobably due to the higher incidence of Caesarean section in these cases.
The analysis of the mode of death (Table 4) is based on post-mortem findings. A scrutiny of the total perinatalmortalityin all hypertensive patients shows an appreciably higher incidence of definite anoxic signs in the babies who succumbed; but this is particularly evident in the stillbirth series, for there is a higher incidence of Mode 3 deaths; and Mode 3 and Mode 4 deaths together account for more than 50 % of the total. A scrutiny of neonatal deaths in all chronic hypertensive mothers indicates that there is little or no difference in the mode of death in this as compared with the total product series. Thus, once a living child from an averagely hypertensive mother has been delivered, it does not appear to be exposed to any unusual risk.
If the 'fatality stage' for stillbirths is broken down by grades of hypertension, I think it is just possible to state that the more severe the degree of hypertension the greater is the risk of death before the onset of labour (69 % of 13 fatalities in cases of mild hypertension, 72% of 7 fatalities, and 78 % of 9 fatalities in cases of moderate and severe hypertension respectively).
Examining the total perinatal mortality in the severely hypertensive grade only, it is seen that even neonatal fatalities showed signs of anoxia, e.g. massive intraventricular hmmorrhage. Surveying Table 5 I think one can hazard a fairly legitimate guess that virtually all babies born of severely hypertensive mothers died with anoxic signs.
This study covers a long series of cases and the statistics are reassuring. As regards perinatal mortality the prognosis for the mildly hypertensive mother is better than the average for the country as a whole: for the moderately hypertensive mother it is fair, and it is only in the cases of severe hypertension that the prognosis should be guarded. The last group of mothers do definitely seem to run a greater risk of intrauterine death; and it is likely that this, when it does occur, will be associated with signs of foetal anoxia. If the baby is born alive, however, it does not seem to be exposed to any unusual risks thereafter. Even the severely hypertensive mother has a 75 % chance of producing a baby that will live. These good results are closely associated with very scrupulous antenatal care, the standards of which must not be relaxed.
Mr C K Vartan (British Hospitalfor Mothers and Babies, Woolwich, London) Hypertension in Pregnancy: A New Look It may seem strange that such a familiar and ever-present problem should have been discussed twice in this session (Jeffcoate 1966) but since the sphygmomanometer was not invented till 1898, took at least thirty years to arrive in the Obstetrical Departments and a further ten years before it was in general use, we are in a sense celebrating the diamond jubilee of our interest in the blood pressure in pregnancy. So the problem has not always been with us and it may be appropriate that we re-examine it to see if any change of thought is needed. Nomenclature A leader written in the British Medical Journal (1961 Journal ( , ii, 1007 stated that 'a misnomer can hardly ever be eradicated... in this field the archaic and confusing terminology of the socalled toxxmias of pregnancy has persisted over the years though it has done little other than provide this aspect of obstetrics with an aura of obscurity', and again: 'Both toxaemia and chronic hypertension are singularly slippery and elusive. Are words and their meanings obscuring the truth? ' (Brit. med. J. 1965, i, 738) .
The term toxamia crept unobtrusively into the textbooks in 1906 to explain the auto-intoxication of the body by the waste products of feetal catabolism added to those of the mothernothing to do with albuminuria at this stage. The advice given was to 'promote the free action of the various organs of excretion', advice which the Hastings Tweedie school of thought was to follow with unprecedented zeal.
In his latest Clinical Report the Master of the Rotunda emphasizes the stupidity of this term and states: 'It is a poor reflection of our progress that we should retain such a vague and unsatisfactory term for current use' (Browne 1964) .
But the damage was done, 'toxaemia' was in and a fruitless and hopeless search for the toxin has persisted since. Eventually toxaemia and albu-minuria became synonymous. In the 1930s the title 'albuminuria of pregnancy', a correct and very good title, was changed quite arbitrarily but very dramatically to 'pre-eclampsia' in order to emphasize to practitioners that albuminuria was potentially very seriousand that title too has persisted, thus endowing the pregnant woman with a disease peculiar to herself and, incidentally, taking her out of the hands of the general physician (a fairly dangerous step). It is hardly surprising that this has become the disease of theories! I suggest that when a previously normal woman, or a man for that matter, develops hypertension, cedema and albuminuria acutely, it would have been much better to have said she was suffering from acute hypertension. We would then have brought pre-eclampsia, so-called, and chronic hypertension together as one disorder -Hypertension, (a) acute and (b) chronic. In support of this Pollak in 1956 showed by renal biopsy that 'pre-eclampsia' has a specific renal lesion, differing significantly from those in all other categories of patients.... It is characterized by constricted glomerular capillary lumina, caused primarily by increase in the cytoplasm of the glomerular endothelial cells. The glomerulus returns to normal when pregnancy is over.
McCartney and others in 1964, investigating 14 primigravidw with acute hypertension diagnosed as pre-eclampsia, found 5 to have chronic glomerular nephritis, 2 to have nephrosclerosis, 2 to have normal renal histology and 5 to have the toxemic glomerular lesion. I have no facilities for renal biopsy and we get on satisfactorily without it, but every now and again I get a patient who does something quite unexpected and it would be nice in these cases to see if there were some underlying renal pathology to explain it.
In considering what constitutes hypertension, we are again in difficulty. The American Committee on Maternal Welfare (1952) stated that we should accept the 140/90 standard and many have done so, but this conflicts with Pickering's figures which show that the normal woman does not reach a diastolic pressure of 90 till she is 35 and has in fact put twenty years of potential childbearing behind her (Pickering 1965). I much prefer the 130/70 standard which F J Browne gave us in the 1930s. It probably makes little difference to the woman, as the criteria for admission to hospital are standardized, but, by not being aware of the disorder till the pressure has reached 140/90, we are depriving ourselves of a valuable 'early warning system'. Further, the fact that no two sets of figures, painstakingly collected, are comparable because of our variable standards is surely a good enough reason for coming to an agreement before another fifty years have passed.
